Shionone Inhibits Glomerular Fibirosis by Suppressing NLRP3 Related Inflammasome though SESN2-NRF2/HO-1 Pathway

Background Diabetic nephropathy (DN) is the most common and serious complication of diabetes mellitus. Shionone (SH), an important triterpenoid compound in the root extract of Aster, might exert a protective effect in DN mice and high glucose cultivated glomerular podocytes. The current study aimed...

Full description

Saved in:
Bibliographic Details
Main Authors: Tian Xiao, Hanzhen Zhao, Yucong Wang, Mengyin Chen, Cong Wang, Chen Qiao
Format: Article
Language:English
Published: Korean Diabetes Association 2025-01-01
Series:Diabetes & Metabolism Journal
Subjects:
Online Access:http://e-dmj.org/upload/pdf/dmj-2024-0024.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841527843142500352
author Tian Xiao
Hanzhen Zhao
Yucong Wang
Mengyin Chen
Cong Wang
Chen Qiao
author_facet Tian Xiao
Hanzhen Zhao
Yucong Wang
Mengyin Chen
Cong Wang
Chen Qiao
author_sort Tian Xiao
collection DOAJ
description Background Diabetic nephropathy (DN) is the most common and serious complication of diabetes mellitus. Shionone (SH), an important triterpenoid compound in the root extract of Aster, might exert a protective effect in DN mice and high glucose cultivated glomerular podocytes. The current study aimed to unravel the underlying mechanism by which SH mitigates DN. We postulate that SH stimulates the expression of sestrin-2 (SESN2), a pivotal stress-inducible protein in the anti-inflammasome machinery. Methods We utilized high-fat diet combined with streptozotocin (55 mg/kg intraperitoneal) for DN mice model, and high glucose (30 mM, 48 hours) cultured glomerular podocytes for DN cell model to evaluate the effect of SH. We also preformed experimentation on SESN2 deficiency models (SESN2 knockout mice and SESN2 siRNA in cells) to further prove our hypothesis. Results The results demonstrated that SH effectively suppressed glomerular fibrosis, induced adenosine monophosphate-activated protein kinase (AMPK) phosphorylation, and inhibited NLR family pyrin domain containing 3 (NLRP3) activation. Furthermore, our findings revealed that SH exerted its anti-inflammatory effect through Sesn2-dependent nuclear factor erythroid 2-related factor 2 (Nrf2) nuclear translocation and subsequent activation of its downstream target heme oxygenase-1 (HO-1). Conclusion In summary, our findings suggest that SH serves as a promising therapeutic agent for the treatment of DN-related glomerular fibrosis. SH enhances the expression of SESN2, attenuates α-smooth muscle actin accumulation, and suppresses NLRP3-related inflammation through the Nrf2/HO-1 signaling pathway.
format Article
id doaj-art-9a8a8b3615704001a283e0ac1d3fa0e8
institution Kabale University
issn 2233-6079
2233-6087
language English
publishDate 2025-01-01
publisher Korean Diabetes Association
record_format Article
series Diabetes & Metabolism Journal
spelling doaj-art-9a8a8b3615704001a283e0ac1d3fa0e82025-01-15T07:46:19ZengKorean Diabetes AssociationDiabetes & Metabolism Journal2233-60792233-60872025-01-01491344810.4093/dmj.2024.00242871Shionone Inhibits Glomerular Fibirosis by Suppressing NLRP3 Related Inflammasome though SESN2-NRF2/HO-1 PathwayTian Xiao0Hanzhen Zhao1Yucong Wang2Mengyin Chen3Cong Wang4Chen Qiao5 China Pharmaceutical University, Nanjing, China China Pharmaceutical University, Nanjing, China School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China Department of Pharmacology, Nanjing Medical University, Nanjing, China School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, ChinaBackground Diabetic nephropathy (DN) is the most common and serious complication of diabetes mellitus. Shionone (SH), an important triterpenoid compound in the root extract of Aster, might exert a protective effect in DN mice and high glucose cultivated glomerular podocytes. The current study aimed to unravel the underlying mechanism by which SH mitigates DN. We postulate that SH stimulates the expression of sestrin-2 (SESN2), a pivotal stress-inducible protein in the anti-inflammasome machinery. Methods We utilized high-fat diet combined with streptozotocin (55 mg/kg intraperitoneal) for DN mice model, and high glucose (30 mM, 48 hours) cultured glomerular podocytes for DN cell model to evaluate the effect of SH. We also preformed experimentation on SESN2 deficiency models (SESN2 knockout mice and SESN2 siRNA in cells) to further prove our hypothesis. Results The results demonstrated that SH effectively suppressed glomerular fibrosis, induced adenosine monophosphate-activated protein kinase (AMPK) phosphorylation, and inhibited NLR family pyrin domain containing 3 (NLRP3) activation. Furthermore, our findings revealed that SH exerted its anti-inflammatory effect through Sesn2-dependent nuclear factor erythroid 2-related factor 2 (Nrf2) nuclear translocation and subsequent activation of its downstream target heme oxygenase-1 (HO-1). Conclusion In summary, our findings suggest that SH serves as a promising therapeutic agent for the treatment of DN-related glomerular fibrosis. SH enhances the expression of SESN2, attenuates α-smooth muscle actin accumulation, and suppresses NLRP3-related inflammation through the Nrf2/HO-1 signaling pathway.http://e-dmj.org/upload/pdf/dmj-2024-0024.pdfnlr family, pyrin domain-containing 3 proteinsesn 2 proteinshionone
spellingShingle Tian Xiao
Hanzhen Zhao
Yucong Wang
Mengyin Chen
Cong Wang
Chen Qiao
Shionone Inhibits Glomerular Fibirosis by Suppressing NLRP3 Related Inflammasome though SESN2-NRF2/HO-1 Pathway
Diabetes & Metabolism Journal
nlr family, pyrin domain-containing 3 protein
sesn 2 protein
shionone
title Shionone Inhibits Glomerular Fibirosis by Suppressing NLRP3 Related Inflammasome though SESN2-NRF2/HO-1 Pathway
title_full Shionone Inhibits Glomerular Fibirosis by Suppressing NLRP3 Related Inflammasome though SESN2-NRF2/HO-1 Pathway
title_fullStr Shionone Inhibits Glomerular Fibirosis by Suppressing NLRP3 Related Inflammasome though SESN2-NRF2/HO-1 Pathway
title_full_unstemmed Shionone Inhibits Glomerular Fibirosis by Suppressing NLRP3 Related Inflammasome though SESN2-NRF2/HO-1 Pathway
title_short Shionone Inhibits Glomerular Fibirosis by Suppressing NLRP3 Related Inflammasome though SESN2-NRF2/HO-1 Pathway
title_sort shionone inhibits glomerular fibirosis by suppressing nlrp3 related inflammasome though sesn2 nrf2 ho 1 pathway
topic nlr family, pyrin domain-containing 3 protein
sesn 2 protein
shionone
url http://e-dmj.org/upload/pdf/dmj-2024-0024.pdf
work_keys_str_mv AT tianxiao shiononeinhibitsglomerularfibirosisbysuppressingnlrp3relatedinflammasomethoughsesn2nrf2ho1pathway
AT hanzhenzhao shiononeinhibitsglomerularfibirosisbysuppressingnlrp3relatedinflammasomethoughsesn2nrf2ho1pathway
AT yucongwang shiononeinhibitsglomerularfibirosisbysuppressingnlrp3relatedinflammasomethoughsesn2nrf2ho1pathway
AT mengyinchen shiononeinhibitsglomerularfibirosisbysuppressingnlrp3relatedinflammasomethoughsesn2nrf2ho1pathway
AT congwang shiononeinhibitsglomerularfibirosisbysuppressingnlrp3relatedinflammasomethoughsesn2nrf2ho1pathway
AT chenqiao shiononeinhibitsglomerularfibirosisbysuppressingnlrp3relatedinflammasomethoughsesn2nrf2ho1pathway